UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetic and Pharmacodynamic Properties of Meropenem

Clinical infectious diseases, 2008-09, Vol.47 (Supplement-1), p.S32-S40

Nicolau, David P.

2008

Volltextzugriff (PDF)

Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge

Emerging microbes & infections, 2022-12, Vol.11 (1), p.811-814

2022

Volltextzugriff (PDF)

Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy, 2011-06, Vol.55 (6), p.3002-3004

2011

Volltextzugriff (PDF)

Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Volltextzugriff (PDF)

Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers

Antimicrobial Agents and Chemotherapy, 2013-07, Vol.57 (7), p.3299-3306

2013

Volltextzugriff (PDF)

Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials

Expert opinion on pharmacotherapy, 2015-02, Vol.16 (2), p.159-177

2015

Volltextzugriff (PDF)

Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens

Journal of antimicrobial chemotherapy, 2015-10, Vol.70 (10), p.2862-2869

2015

Volltextzugriff (PDF)

Augmented Renal Clearance and How to Augment Antibiotic Dosing

Antibiotics (Basel), 2020-07, Vol.9 (7), p.393

2020

Volltextzugriff (PDF)

Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria

Expert opinion on investigational drugs, 2018-04, Vol.27 (4), p.325-338

2018

Volltextzugriff (PDF)

Comparative in vivo activity of human-simulated plasma and epithelial lining fluid exposures of WCK 5222 (cefepime/zidebactam) against KPC- and OXA-48-like-producing Klebsiella pneumoniae in the neutropenic murine pneumonia model

Journal of antimicrobial chemotherapy, 2021-08, Vol.76 (9), p.2310-2316

2021

Volltextzugriff (PDF)

Clinical Pharmacodynamics of Antipseudomonal Cephalosporins in Patients with Ventilator-Associated Pneumonia

Antimicrobial Agents and Chemotherapy, 2014-03, Vol.58 (3), p.1359-1364

2014

Volltextzugriff (PDF)

Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections

Antimicrobial Agents and Chemotherapy, 2007-05, Vol.51 (5), p.1725-1730

2007

Volltextzugriff (PDF)

Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae , and Pseudomonas aeruginosa From US Hospitals

Clinical therapeutics, 2015-07, Vol.37 (7), p.1564-1571

2015

Volltextzugriff (PDF)

Phase I, Open-Label, Safety and Pharmacokinetic Study To Assess Bronchopulmonary Disposition of Intravenous Eravacycline in Healthy Men and Women

Antimicrobial agents and chemotherapy, 2014-04, Vol.58 (4), p.2113-2118

2014

Volltextzugriff (PDF)

Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women

American journal of obstetrics and gynecology, 2015-09, Vol.213 (3), p.415.e1-415.e8

2015

Volltextzugriff (PDF)

Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects

Journal of antimicrobial chemotherapy, 2023-03, Vol.78 (3), p.703-709

2023

Volltextzugriff (PDF)

In Vitro Pharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy, 2014-02, Vol.58 (2), p.874-879

2014

Volltextzugriff (PDF)

Comparative In Vitro and In Vivo Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2012-12, Vol.56 (12), p.6137-6146

2012

Volltextzugriff (PDF)

Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4197-4207

2013

Volltextzugriff (PDF)

Comparison of 2 Blood Culture Media Shows Significant Differences in Bacterial Recovery for Patients on Antimicrobial Therapy

Clinical infectious diseases, 2013-03, Vol.56 (6), p.790-797

2013

Volltextzugriff (PDF)

Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae

The Journal of urology, 2015-08, Vol.194 (2), p.563-570

2015

Volltextzugriff (PDF)

Multicenter Evaluation of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Inhibitory Activity against Meropenem-Nonsusceptible Pseudomonas aeruginosa from Blood, Respiratory Tract, and Wounds

Antimicrobial agents and chemotherapy, 2017-10, Vol.61 (10)

2017

Volltextzugriff (PDF)

Efficacies of Ceftazidime-Avibactam and Ceftazidime against Pseudomonas aeruginosa in a Murine Lung Infection Model

Antimicrobial Agents and Chemotherapy, 2014-03, Vol.58 (3), p.1365-1371

2014

Volltextzugriff (PDF)

Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2627-2634

2012

Volltextzugriff (PDF)

Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2010-03, Vol.54 (3), p.1111-1116

2010

Volltextzugriff (PDF)

1 – 25 von 1.014

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(973)
Mit Volltextzugriff
(860)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(740)
Life Sciences & Biomedicine
(730)
Humans
(516)
Pharmacology & Pharmacy
(469)
Microbiology
(379)
Infectious Diseases
(297)
Female
(261)
Biological And Medical Sciences
(259)
Medical Sciences
(256)
Microbial Sensitivity Tests
(250)
Pharmacology. Drug Treatments
(222)
Anti-Bacterial Agents - Pharmacology
(200)
Male
(195)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(184)
Anti-Bacterial Agents - Therapeutic Use
(164)
Anti-Bacterial Agents - Pharmacokinetics
(161)
Animals
(159)
Middle Aged
(144)
Adult
(141)
Anti-Bacterial Agents - Administration & Dosage
(138)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic and Pharmacodynamic Properties of Meropenem

Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge

Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae

Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model

Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers

Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials

Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens

Augmented Renal Clearance and How to Augment Antibiotic Dosing

Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria

Comparative in vivo activity of human-simulated plasma and epithelial lining fluid exposures of WCK 5222 (cefepime/zidebactam) against KPC- and OXA-48-like-producing Klebsiella pneumoniae in the neutropenic murine pneumonia model

Clinical Pharmacodynamics of Antipseudomonal Cephalosporins in Patients with Ventilator-Associated Pneumonia

Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections

Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae , and Pseudomonas aeruginosa From US Hospitals

Phase I, Open-Label, Safety and Pharmacokinetic Study To Assess Bronchopulmonary Disposition of Intravenous Eravacycline in Healthy Men and Women

Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women

Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects

In Vitro Pharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii

Comparative In Vitro and In Vivo Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa

Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa

Comparison of 2 Blood Culture Media Shows Significant Differences in Bacterial Recovery for Patients on Antimicrobial Therapy

Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae

Multicenter Evaluation of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Inhibitory Activity against Meropenem-Nonsusceptible Pseudomonas aeruginosa from Blood, Respiratory Tract, and Wounds

Efficacies of Ceftazidime-Avibactam and Ceftazidime against Pseudomonas aeruginosa in a Murine Lung Infection Model

Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers

Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa

Suchergebnisse filtern